← Back to guidelines
Urology55 papers

Male sexual precocity with adrenal hyperplasia

Last edited: 4/14/2026

Overview

Male sexual precocity with adrenal hyperplasia refers to the premature development of secondary sexual characteristics in males due to excessive adrenal androgen production, often resulting from congenital adrenal hyperplasia (CAH). 2

Diagnosis

  • Clinical presentation includes early pubarche, rapid growth velocity, and potential virilization. 2
  • Elevated levels of androgens (e.g., testosterone, DHEA-S) and ACTH stimulation tests are crucial for diagnosis. 2
  • Genetic testing may identify specific mutations associated with CAH. 2
  • Management

  • First-line treatment: Glucocorticoids (e.g., hydrocortisone) to suppress ACTH and reduce androgen production. 2
  • Adjunctive therapies: Mineralocorticoids (e.g., fludrocortisone) if mineralocorticoid deficiency is present. 2
  • Regular monitoring of growth, bone health, and adrenal function is essential. 2
  • Special Populations

  • Pediatrics: Early intervention with glucocorticoids is critical to prevent irreversible effects like precocious puberty and short stature. 2
  • Comorbidities: Management should consider potential interactions with other endocrine disorders; individualized treatment plans are necessary. 2
  • Key Recommendations

  • Initiate glucocorticoid therapy promptly in diagnosed cases to suppress androgen production and prevent virilization. (Evidence: Strong 2)
  • Include mineralocorticoid supplementation if mineralocorticoid deficiency is identified to maintain electrolyte balance. (Evidence: Strong 2)
  • Regularly monitor growth parameters and adrenal function in pediatric patients to adjust treatment as needed. (Evidence: Moderate 2)
  • References

    1 Reddy AG, Dick BP, Natale C, Akula KP, Yousif A, Hellstrom WJG. Application of Botulinum Neurotoxin in Male Sexual Dysfunction: Where Are We Now?. Sexual medicine reviews 2021. link 2 Buvat J, Maggi M, Gooren L, Guay AT, Kaufman J, Morgentaler A et al.. Endocrine aspects of male sexual dysfunctions. The journal of sexual medicine 2010. link 3 Platano G, Margraf J, Alder J, Bitzer J. Psychosocial factors and therapeutic approaches in the context of sexual history taking in men: a study conducted among Swiss general practitioners and urologists. The journal of sexual medicine 2008. link 4 Angeletti LR. For a history of andrology. Medicina nei secoli 2001. link

    Original source

    1. [1]
      Application of Botulinum Neurotoxin in Male Sexual Dysfunction: Where Are We Now?Reddy AG, Dick BP, Natale C, Akula KP, Yousif A, Hellstrom WJG Sexual medicine reviews (2021)
    2. [2]
      Endocrine aspects of male sexual dysfunctions.Buvat J, Maggi M, Gooren L, Guay AT, Kaufman J, Morgentaler A et al. The journal of sexual medicine (2010)
    3. [3]
    4. [4]
      For a history of andrology.Angeletti LR Medicina nei secoli (2001)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG